Stay updated on CB-839 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.
Latest updates to the CB-839 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedLocations section was updated with a new Locations header and added state entries (California, Florida, Georgia, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas), while state-specific entries were removed, and the page revision updated to v3.3.3.SummaryDifference0.9%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 was added to the page and Revision: v3.2.0 was removed.SummaryDifference0.0%
- Check41 days agoChange DetectedRemoved a site-wide funding-status notice about government funding. The study details page content remains unchanged.SummaryDifference0.3%
- Check55 days agoChange DetectedScreenshots show only minor UI/label tweaks with no change to core sections such as the Brief Summary, Eligibility Criteria, Study Plan, or Locations, and the study title, conditions, and primary outcomes remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check84 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0), indicating updated deployment; removal of the prior version tag (v3.1.0) accompanies the upgrade.SummaryDifference4%
- Check91 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.